Recent and Anticipated Novel Drug Approvals for 2023 and 2024
December 2, 2023
In this podcast, Dr. Matthew Rim and Dr. Andrew Levitsky discuss the AJHP Special Feature, “Recent and Anticipated Novel Drug Approvals for 2023 and 2024,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
SPEAKERS
Matthew Rim, PharmD, MS, FASHP is the System Director of Ambulatory Pharmacy Services at Northwestern Medicine in Chicago. Rim earned his PharmD from the Western University of Health Sciences and MS from University of Utah while completing the PGY1/PGY2 HSPAL residency at University of Utah Health. Rim’s involvement in ASHP includes the Chair of the Section of Specialty Pharmacy Practitioners, senior consultant, and contributing editor. Rim was recognized as the Fellow of ASHP in 2022.
Andrew Levitsky, PharmD, BCPS is a Senior Director of Clinical Pharmacy at IPD Analytics where he oversees the creation of budget impact models for new and emerging therapies. Previously, Dr. Levitsky held clinical leadership positions at Boston Medical Center, BMC HealthNet Plan, Tufts Medical Center, and Lahey Health. He received his Pharm.D. from the University of Rhode Island in 1998 and completed a Pharmacy Practice Residency at the Bronx Veterans Affairs Medical Center in 1999.
ADVERTISEMENT
LISTEN ON
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.